Pituitary, Thyroid & Adrenal Disorders
Conference Coverage
Post-parathyroidectomy follow-up may need to be open-ended
Key clinical point: Long-term recurrence rates for hyperparathyroidism (HPT) after “curative” parathyroidectomy are likely higher than previously...
Conference Coverage
Negative sestamibi scan for primary hyperparathyroidism can mean no referral or surgery
BALTIMORE – Study data indicate that endocrinologists are using sestamibi results to determine whether or not to refer a patient for...
Conference Coverage
VIDEO: Proposed revision of medullary thyroid cancer staging improves risk-stratification analysis
BOSTON – An analysis of data from medullary thyroid cancer patients that partitioned the patients into groups with similar overall survival has...
Conference Coverage
VIDEO: More routine use of unilateral thyroidectomy advocated for papillary thyroid microcarcinoma
BOSTON – Unilateral thyroidectomy has comparable recurrence results when compared to bilateral surgery and is not associated with either cord...
Conference Coverage
Morning cortisol rules out adrenal insufficiency
BOSTON – Measuring morning cortisol cuts ACTH-stimulation need in half.
Conference Coverage
VIDEO: Low thyroid function increases odds of type 2 diabetes
Low thyroid function is implicated in a heightened risk for the development of type 2 diabetes and the progress to prediabetes.
News
Subclinical hyperthyroidism disease tied to higher mortality in elderly
Key clinical point: Subclinical hyperthyroidism and hypothyroidism are both associated with increased mortality in the elderly. Major finding: The...
Conference Coverage
Treating maternal subclinical hypothyroidism doesn’t improve childhood IQ
Key clinical point: Levothyroxine for women with subclinical hypothyroidism didn’t boost childhood cognition. Major finding: Child IQ at 5 years...
News
Gender identity disorders in males associated with MS
News
Endocrine Society issues first-ever guidelines for primary adrenal insufficiency
News
Novel agent for adult GH can be administered once weekly
A novel reversible albumin-binding human growth hormone derivative administered subcutaneously once weekly for 4 weeks was safe and effective in...